Bemdaneprocel is a cell therapy composed of human embryonic stem cell-derived midbrain dopaminergic neuron progenitor cells.
Subtle fatigue, pain or brain fog could signal early Parkinson's in women rather than menopause – learn 11 quiet warning ...
For many individuals living with Parkinson's disease and those in its "prodromal" or early stages before movement impairment, there is a distressing gap between how they feel their brain is working ...
A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool, called VisionMD, helps doctors ...
Morning Overview on MSN
Study links gut microbiome shifts to Parkinson’s risk before symptoms start
Most people diagnosed with Parkinson’s disease first notice a tremor in one hand, a stiffness in their gait, or a slowness they can’t quite explain. By that point, an estimated 50 to 80 percent of the ...
From fatigue to sleep issues, early symptoms can be subtle – and are often mistaken for menopause or ageing ...
Exposure to ambient trichloroethylene (TCE) was tied to an increased risk of Parkinson's disease. People living in areas with the highest outdoor TCE levels had a 10% higher relative risk. The EPA ...
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...
Odds for developing Parkinson’s disease increased with newer groundwater and with carbonate aquifers, according to a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results